Davos 2025 - giving AI responsibility to CDOs results in great AI no-one uses, says Sanofi CEO Paul Hudson [People] delegate AI to CDOs, and it's the biggest mistake you can make.

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Researchers at Leipzig University have developed a new process for reversing the polarity of chemical compounds, also known ...

Despite all of today’s options for optimizing the bioprocessing of fungal secondary metabolites, researchers pointed out the ...

The blood–brain barrier is the biggest challenge to the development of drugs that target the CNS. Most capillary beds leak plasma contents between and across endothelial cells by way of window-like ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

Immunopathologies encompass a range of conditions known for their defined pathophysiology but lack safe and effective treatment options. These diseases ...

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and its affiliated Institute for Research in Immunology and Cancer are working ...

Drug testing may be required as a prerequisite for some jobs. State laws may dictate when private employers can require drug tests and how they can use the results. Job candidates for “safety ...

UnitedHealth, in which slain CEO Brian Thompson was employed, has been allegedly accused of overcharging patients suffering ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with an alcohol) to be locked treasure chests of possibilities. Ubiquitous as ...